mebendazole has been researched along with Disease, Pulmonary in 1 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Combined surgery and continuous administration of albendazole at high dosage may allow alveolar echinococcosis patients to survive more than 30 years after diagnosis despite multi-organ involvement." | 1.39 | 30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient. ( Bardonnet, K; Blagosklonov, O; Bresson-Hadni, S; Delabrousse, E; Grenouillet, F; Mantion, GA; Miguet, JP; Vuitton, DA, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardonnet, K | 1 |
| Vuitton, DA | 1 |
| Grenouillet, F | 1 |
| Mantion, GA | 1 |
| Delabrousse, E | 1 |
| Blagosklonov, O | 1 |
| Miguet, JP | 1 |
| Bresson-Hadni, S | 1 |
1 other study available for mebendazole and Disease, Pulmonary
| Article | Year |
|---|---|
30-yr course and favorable outcome of alveolar echinococcosis despite multiple metastatic organ involvement in a non-immune suppressed patient.
Topics: Adult; Albendazole; Antinematodal Agents; Echinococcosis; Echinococcosis, Hepatic; Follow-Up Studies | 2013 |